Truist Securities Starts Alkermes (ALKS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $45.89 +0.44%
Rating Summary:
16 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
16 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
Truist Securities analyst Danielle Brill initiates coverage on Alkermes (NASDAQ: ALKS) with a Buy rating and a price target of $55.00.
For an analyst ratings summary and ratings history on Alkermes click here. For more ratings news on Alkermes click here.
Shares of Alkermes closed at $40.10 yesterday.
You May Also Be Interested In
- Alkermes (ALKS) PT Raised to $50 at H.C. Wainwright
- Alkermes (ALKS) PT Raised to $68 at Wells Fargo
- H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
